-
Tue25Sep2018Fri28Sep2018
-
Thu27Sep2018Fri28Sep2018
-
Thu11Oct2018Fri12Oct2018
-
Wed17Oct2018Sat20Oct2018Cape Town, South Africa
-
Thu18Oct2018Sun21Oct2018
-
Mon29Oct2018Tue30Oct2018
-
Thu01Nov2018Fri02Nov2018
-
Thu01Nov2018Fri02Nov2018
Latest News
Live from CIRSE 2018: Three-year results from global study confirm the...
The largest prospective, independently-adjudicated study of drug coated balloons (DCBs) in a broad range of lesions in real-world patients confirms the safety and performance...
Features
The dialysis access landscape in 2018: Challenges, advances and future directions
Guidelines of the European Society for Vascular Surgery1 give an overview of the current best evidence for vascular access for dialysis. Although these guidelines...
Combined carotid and coronary revascularisation: Is this a good idea?
George Chrysant gives an overview of combined revascularisation interventions for coronary and carotid disease, arguing that "carotid artery stenting and coronary artery bypass grafting...
Videos
Andrew Holden (Auckland, News Zealand) interviews Stefan Mueller-Huelsbeck (Flensburg, Germany) to distil the key findings of the IMPERIAL trial one-year data that were presented for the very first time at CIRSE 2018 in Lisbon.
In the randomised controlled trial, Eluvia,...
(Visited 46,142 times, 47 visits today)
